BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22052881)

  • 1. T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses.
    Sharma S; Sundararajan A; Suryawanshi A; Kumar N; Veiga-Parga T; Kuchroo VK; Thomas PG; Sangster MY; Rouse BT
    Proc Natl Acad Sci U S A; 2011 Nov; 108(47):19001-6. PubMed ID: 22052881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response.
    Sehrawat S; Reddy PB; Rajasagi N; Suryawanshi A; Hirashima M; Rouse BT
    PLoS Pathog; 2010 May; 6(5):e1000882. PubMed ID: 20463811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency.
    Reddy PB; Sehrawat S; Suryawanshi A; Rajasagi NK; Mulik S; Hirashima M; Rouse BT
    J Immunol; 2011 Dec; 187(11):5745-55. PubMed ID: 22021615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia.
    Zhou Q; Munger ME; Veenstra RG; Weigel BJ; Hirashima M; Munn DH; Murphy WJ; Azuma M; Anderson AC; Kuchroo VK; Blazar BR
    Blood; 2011 Apr; 117(17):4501-10. PubMed ID: 21385853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.
    Nagahara K; Arikawa T; Oomizu S; Kontani K; Nobumoto A; Tateno H; Watanabe K; Niki T; Katoh S; Miyake M; Nagahata S; Hirabayashi J; Kuchroo VK; Yamauchi A; Hirashima M
    J Immunol; 2008 Dec; 181(11):7660-9. PubMed ID: 19017954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of the NOD-Like Receptor NLRC5 Results in Decreased CD8
    Lupfer CR; Stokes KL; Kuriakose T; Kanneganti TD
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.
    Liu Y; Ji H; Zhang Y; Shen X; Gao F; He X; Li GA; Busuttil RW; Kuchroo VK; Kupiec-Weglinski JW
    J Hepatol; 2015 Mar; 62(3):563-72. PubMed ID: 25450716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.
    Wei J; Waithman J; Lata R; Mifsud NA; Cebon J; Kay T; Smyth MJ; Sadler AJ; Chen W
    J Immunol; 2010 Nov; 185(10):6013-22. PubMed ID: 20956347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication.
    Hastings AK; Erickson JJ; Schuster JE; Boyd KL; Tollefson SJ; Johnson M; Gilchuk P; Joyce S; Williams JV
    J Virol; 2015 Apr; 89(8):4405-20. PubMed ID: 25653440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts.
    Wang F; He W; Yuan J; Wu K; Zhou H; Zhang W; Chen ZK
    Transpl Immunol; 2008 Apr; 19(1):12-9. PubMed ID: 18346632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone-Based Contraceptives Reduce Adaptive Immune Responses and Protection against Sequential Influenza A Virus Infections.
    Hall OJ; Nachbagauer R; Vermillion MS; Fink AL; Phuong V; Krammer F; Klein SL
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
    Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
    Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells.
    Veenstra RG; Taylor PA; Zhou Q; Panoskaltsis-Mortari A; Hirashima M; Flynn R; Liu D; Anderson AC; Strom TB; Kuchroo VK; Blazar BR
    Blood; 2012 Jul; 120(3):682-90. PubMed ID: 22677125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner.
    Uchida Y; Ke B; Freitas MC; Yagita H; Akiba H; Busuttil RW; Najafian N; Kupiec-Weglinski JW
    Gastroenterology; 2010 Dec; 139(6):2195-206. PubMed ID: 20637206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIM-3 does not act as a receptor for galectin-9.
    Leitner J; Rieger A; Pickl WF; Zlabinger G; Grabmeier-Pfistershammer K; Steinberger P
    PLoS Pathog; 2013 Mar; 9(3):e1003253. PubMed ID: 23555261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.
    Brincks EL; Gurung P; Langlois RA; Hemann EA; Legge KL; Griffith TS
    J Immunol; 2011 Nov; 187(9):4581-8. PubMed ID: 21940678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Ethanol Consumption Reduces Existing CD8 T Cell Memory and Is Associated with Lesions in Protection against Secondary Influenza A Virus Infections.
    Zacharias ZR; Legge KL
    J Immunol; 2019 Dec; 203(12):3313-3324. PubMed ID: 31712384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells.
    Wang F; Wan L; Zhang C; Zheng X; Li J; Chen ZK
    Immunobiology; 2009; 214(5):342-9. PubMed ID: 19362679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-9 regulates T helper cell function independently of Tim-3.
    Su EW; Bi S; Kane LP
    Glycobiology; 2011 Oct; 21(10):1258-65. PubMed ID: 21187321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell NLRC4 regulates influenza A virus-specific CD4 T cell responses through FasL expression.
    Hornick EE; Dagvadorj J; Zacharias ZR; Miller AM; Langlois RA; Chen P; Legge KL; Bishop GA; Sutterwala FS; Cassel SL
    J Clin Invest; 2019 Apr; 129(7):2888-2897. PubMed ID: 31038471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.